Viking Therapeutics Corp (VKTX): Earnings per share for the last twelve months

Symbol and logo of brand vikingtherapeutics.com (VKTX)

Viking Therapeutics (VKTX) possesses colossal market influence due to the development of highly effective receptor agonists. Patent protection and stringent FDA oversight preclude the rapid emergence of generics. Net income per share over the last four quarters demonstrates business adaptability, with the current level sitting around -5.45. Process stability is ensured through a strict protocol for the delivery of biosamples via international hubs.

VKTX (vikingtherapeutics.com) Net earnings per share for the trailing year history from 07/04/2022 to 11/18/2026

Viking Pharma (VKTX) - metric breakdowns and financial figures

- stock price and consensus target price:
- stock exchange capitalization data:
General company analysis:Viking Therapeutics Corp (VKTX)
Flagship merchandise of Viking Therapeutics Inc

High R&D investments by Viking Therapeutics (VKTX) and a temporary lack of revenue define the specifics of current financial results. Analyzing this chart of net income per share over the last 12 months, an investor sees the result of dividing total income by the number of shares, which allows for an assessment of the real value of ownership considering the fresh influx of capital and the stability of the cash reserve.

Main competitors

biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months SUPN (supernus.com)|Net earnings per share for the last four quarters Catalyst Pharmaceuticals Inc|Denali Therapeutics Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year HRMY|BHVN: Net earnings per share for the last 12 months|Earnings per share for the trailing year AMLX (Amylyx Pharmaceuticals)|Trevi Therapeutics, Inc. (TRVI) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CBLL (CeriBell Corp)|Earnings per share for the last twelve months Prothena Biosciences (PRTA)|Net earnings per share for the last four quarters Alector|Net earnings per share (EPS TTM) ANNX (annexonbio.com)|Earnings per share for the trailing year OMER|NGNE: Net earnings per share for the last 12 months|ACIU (AC Immune Corp) - Earnings per share for the last 12 months|VYGR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months TVGN (Tevogen Bio)|Net earnings per share (EPS TTM) ACOG|CGTX - Net earnings per one share for the last twelve months|Inhibikase Pharma - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters cassavasciences.com (SAVA)|Assertio Holdings - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Coya Therapeutics COYA|VTGN: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months OVID|Earnings per share for the last twelve months Acumen Pharmaceuticals|CRVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATHE|CLNN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months PepGen Inc PEPG|Net earnings per share for the last four quarters jupiterneurosciences.com (JUNS)|Relmada Therapeutics, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ANVS (annovisbio.com)|Grace Tx (GRCE) - Earnings per share for the last twelve months|Firefly Neuroscience (AIFF) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Net earnings per share (EPS TTM) MetaVia, Inc. (MTVA)|NeurAxis, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Helius Medical HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Earnings per share for the last twelve months|Athira Pharma, Inc. - Earnings per share for the trailing year|ADXN (Addex) - Net earnings per share (EPS TTM)|Alzamend Neuro, Inc. - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CYCN|PTIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months pasitheaclinics.com KTTA|Earnings per share for the trailing year CRGT|Avenue Therapeutics Inc - Net earnings per share (EPS TTM)|Brainstorm Cell Therapeutics, Inc. (BCLI) - Net earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Chromocell - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ITCI (intracellulartherapies.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Longboard Pharma (LBPH)|Marinus - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGN (nkgenbiotech.com)|NeuroBo Pharma - Earnings per share for the last twelve months|Sage Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year